Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG). [electronic resource]
Producer: 20090203Description: 557-63 p. digitalISSN:- 1573-7217
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- therapy
- Chemotherapy, Adjuvant -- methods
- Cyclophosphamide -- therapeutic use
- Dose-Response Relationship, Drug
- Epirubicin -- therapeutic use
- Female
- Filgrastim
- Fluorouracil -- therapeutic use
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Medical Oncology -- methods
- Middle Aged
- Polyethylene Glycols
- Recombinant Proteins
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.